Involvement of spinal orexin A in the electroacupuncture analgesia in a rat model of post-laparotomy pain

BMC Complementary and Alternative Medicine

Gen-Cheng Wu¹  Yan-Qing Wang²  Zhi-Fu Wang²  Sheng Xiao²  Jian-Wei Jiang²  Qi-Liang Mao-Ying²  Fang Xia²  Wen-Li Mi²  Xiao-Ming Feng³ 

[1] P.O. Box 291, 138 Yi Xue Yuan Road, Shanghai, 200032, China;Department of Integrative Medicine and Neurobiology, Institute of Acupuncture Research, WHO Collaborating Center for Traditional Medicine, State Key Laboratory of Medical Neurobiology, Institutes of Brain Science, Shanghai Medical College, Fudan University, Shanghai, 20032, China;Shanghai Institute of Acupuncture-Moxibustion and Meridian, Shanghai, 200030, China

关键词: SB-334867;    OX1R;    Post-laparotomy pain;    Orexin A;    Electroacupuncture analgesia;   

Others  :  1231489
DOI  :  10.1186/1472-6882-12-225

 received in 2012-06-13, accepted in 2012-10-25,  发布年份 2012

【 摘 要 】

Background

Orexin A (OXA, hypocretin/hcrt 1) is a newly discovered potential analgesic substance. However, whether OXA is involved in acupuncture analgesia remains unknown. The present study was designed to investigate the involvement of spinal OXA in electroacupuncture (EA) analgesia.

Methods

A modified rat model of post-laparotomy pain was adopted and evaluated. Von Frey filaments were used to measure mechanical allodynia of the hind paw and abdomen. EA at 2/15 Hz or 2/100 Hz was performed once on the bilateral ST36 and SP6 for 30 min perioperatively. SB-334867, a selective orexin 1 receptor (OX1R) antagonist with a higher affinity for OXA than OXB, was intrathecally injected to observe its effect on EA analgesia.

Results

OXA at 0.3 nmol and EA at 2/15 Hz produced respective analgesic effects on the model (P<0.05). Pre-surgical intrathecal administered of SB-334867 30 nmol antagonized OXA analgesia and attenuated the analgesic effect of EA (P<0.05). However, SB-334867 did not block fentanyl-induced analgesia (P>0.05). In addition, naloxone, a selective opioid receptor antagonist, failed to antagonize OXA-induced analgesia (P>0.05).

Conclusions

The results of the present study indicate the involvement of OXA in EA analgesia via OX1R in an opioid-independent way.

【 授权许可】

   
2012 Feng et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Fig. 2.

【 参考文献 】

• [1]Kitade T, Odahara Y, Shinohara S, Ikeuchi T, Sakai T, Morikawa K, Minamikawa M, Toyota S, Kawachi A, Hyodo M, et al.: Studies on the enhanced effect of acupuncture analgesia and acupuncture anesthesia by D-phenylalanine (first report)–effect on pain threshold and inhibition by naloxone. Acupunct Electrother Res 1988, 13(2–3):87-97.
• [2]Chapman CR: Modulation of experimental dental pain in man with acupuncture and by transcutaneous electric stimulation. Ann Anesthesiol Fr 1978, 19(5):427-433.
• [3]Ernst M, Lee MH: Influence of naloxone on electro-acupuncture analgesia using an experimental dental pain test, Review of possible mechanisms of action. Acupunct Electrother Res 1987, 12(1):5-22.
• [4]Eriksson SV, Lundeberg T, Lundeberg S: Interaction of diazepam and naloxone on acupuncture induced pain relief. Am J Chin Med 1991, 19(1):1-7.
• [5]Chapman CR, Benedetti C, Colpitts YH, Gerlach R: Naloxone fails to reverse pain thresholds elevated by acupuncture: acupuncture analgesia reconsidered. Pain 1983, 16(1):13-31.
• [6]Koo ST, Park YI, Lim KS, Chung K, Chung JM: Acupuncture analgesia in a new rat model of ankle sprain pain. Pain 2002, 99(3):423-431.
• [7]Lim S, Ryu YH, Kim ST, Hong MS, Park HJ: Acupuncture increases neuropeptide Y expression in hippocampus of maternally-separated rats. Neurosci Lett 2003, 343(1):49-52.
• [8]Bucinskaite V, Theodorsson E, Crumpton K, Stenfors C, Ekblom A, Lundeberg T: Effects of repeated sensory stimulation (electro-acupuncture) and physical exercise (running) on open-field behaviour and concentrations of neuropeptides in the hippocampus in WKY and SHR rats. Eur J Neurosci 1996, 8(2):382-387.
• [9]Bucinskaite V, Lundeberg T, Stenfors C, Ekblom A, Dahlin L, Theodorsson E: Effects of electro-acupuncture and physical exercise on regional concentrations of neuropeptides in rat brain. Brain Res 1994, 666(1):128-132.
• [10]Han JS: Acupuncture and endorphins. Neurosci Lett 2004, 361(1–3):258-261.
• [11]Huang CWYH: Characteristics of electroacupuncture-induced analgesia in mice: variation with strain, frequency, intensity and opioid involvement. In. 2002, 945:20-25.
• [12]Zhao ZQ: Neural mechanism underlying acupuncture analgesia. Prog Neurobiol 2008, 85(4):355-375.
• [13]de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FN, et al.: The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998, 95(1):322-327.
• [14]Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richarson JA, Kozlowski GP, Wilson S, et al.: Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92(5):1-696.
• [15]Ferguson AV, Samson WK: The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol 2003, 24(3):141-150.
• [16]Harris GC, Aston-Jones G: Arousal and reward: a dichotomy in orexin function. Trends Neurosci 2006, 29(10):571-577.
• [17]Holmqvist T, Akerman KE, Kukkonen JP: Orexin signaling in recombinant neuron-like cells. FEBS Lett 2002, 526(1–3):11-14.
• [18]Sakurai T: Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis. CNS Neurol Disord Drug Targets 2006, 5(3):313-325.
• [19]Yamamoto T, Saito O, Shono K, Aoe T, Chiba T: Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model. Neurosci Lett 2003, 347(3):183-186.
• [20]Yamamoto T, Saito O, Shono K, Hirasawa S: Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test. Eur J Pharmacol 2003, 481(2–3):175-180.
• [21]Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M, Jeffrey P, Cutler L, Riba I, Johns A, et al.: Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001, 92(1–2):81-90.
• [22]Yoshida Y, Fujiki N, Maki RA, Schwarz D, Nishino S: Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats. Neurosci Lett 2003, 346(3):182-186.
• [23]Cheng JK, Chou RC, Hwang LL, Chiou LC: Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. J Pharmacol Exp Ther 2003, 307(3):1065-1071.
• [24]Chiou LC, Lee HJ, Ho YC, Chen SP, Liao YY, Ma CH, Fan PC, Fuh JL, Wang SJ: Orexins/Hypocretins: pain regulation and cellular actions. Curr Pharm Des 2010, 16(28):3089-3100.
• [25]Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, Naghdi N, Yanai K: Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain 2005, 118(1–2):254-262.
• [26]van den Pol AN: Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 1999, 19(8):3171-3182.
• [27]Date Y, Mondal MS, Matsukura S, Nakazato M: Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci Lett 2000, 288(2):87-90.
• [28]Guan JL, Wang QP, Shioda S: Immunoelectron microscopic examination of orexin-like immunoreactive fibers in the dorsal horn of the rat spinal cord. Brain Res 2003, 987(1):86-92.
• [29]Yamamoto T, Nozaki-Taguchi N, Chiba T: Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br J Pharmacol 2002, 137(2):170-176.
• [30]Roughan JV, Flecknell PA: Behavioural effects of laparotomy and analgesic effects of ketoprofen and carprofen in rats. Pain 2001, 90(1–2):65-74.
• [31]Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16(2):109-110.
• [32]Callahan BL, Gil AS, Levesque A, Mogil JS: Modulation of mechanical and thermal nociceptive sensitivity in the laboratory mouse by behavioral state. J Pain 2008, 9(2):174-184.
• [33]Lei J, You HJ: Variation of pain and vasomotor responses evoked by intramuscular infusion of hypertonic saline in human subjects: Influence of gender and its potential neural mechanisms. Brain Res Bull 2011, 87(6):564-570.
• [34]Watson C, Paxinos G: The rat brain in stereotaxic coordinates. 6th edition. Amsterdam: Academic Press/Elsevier; 2007.
• [35]Feng P, Vurbic D, Wu Z, Strohl KP: Brain orexins and wake regulation in rats exposed to maternal deprivation. Brain Res 2007, 1154:163-172.
• [36]Lin L, Wisor J, Shiba T, Taheri S, Yanai K, Wurts S, Lin X, Vitaterna M, Takahashi J, Lovenberg TW, et al.: Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 2002, 23(12):2203-2211.
• [37]Feng P, Vurbic D, Wu Z, Hu Y, Strohl KP: Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. J Psychopharmacol 2008, 22(7):784-791.
• [38]Lee I, Kim HK, Kim JH, Chung K, Chung JM: The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons. Pain 2007, 133(1–3):9-17.
• [39]Brennan TJ, Vandermeulen EP, Gebhart GF: Characterization of a rat model of incisional pain. Pain 1996, 64(3):493-501.
• [40]Christoph T, Kogel B, Schiene K, Meen M, De Vry J, Friderichs E: Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. Eur J Pharmacol 2005, 507(1–3):87-98.
• [41]Dolan S, Nolan AM: Blockade of metabotropic glutamate receptor 5 activation inhibits mechanical hypersensitivity following abdominal surgery. Eur J Pain 2007, 11(6):644-651.
• [42]Lascelles BD, Waterman AE, Cripps PJ, Livingston A, Henderson G: Central sensitization as a result of surgical pain: investigation of the pre-emptive value of pethidine for ovariohysterectomy in the rat. Pain 1995, 62(2):201-212.
• [43]Ji G, Yu J, Dong Z, Wu G: Changes of Expression of IL-1 Receptor-I mRNA in Rat Periaqueductal Gray after Peripheral Inflammation and Electroacupuncture Analgesia. Acupuncture Research 2003, 28(2):111-114.
• [44]Han JS, Ding XZ, Fan SG: Frequency as the cardinal determinant for electroacupuncture analgesia to be reversed by opioid antagonists. Sheng Li Xue Bao 1986, 38(5):475-482.
• [45]Cheng RS, Pomeranz B: Electroacupuncture analgesia could be mediated by at least two pain-relieving mechanisms; endorphin and non-endorphin systems. Life Sci 1979, 25(23):1957-1962.
• [46]Huang C, Wang Y, Chang JK, Han JS: Endomorphin and mu-opioid receptors in mouse brain mediate the analgesic effect induced by 2 Hz but not 100 Hz electroacupuncture stimulation. Neurosci Lett 2000, 294(3):159-162.
• [47]Han Z, Jiang YH, Wan Y, Wang Y, Chang JK, Han JS: Endomorphin-1 mediates 2 Hz but not 100 Hz electroacupuncture analgesia in the rat. Neurosci Lett 1999, 274(2):75-78.
• [48]Chen XH, Han JS: Analgesia induced by electroacupuncture of different frequencies is mediated by different types of opioid receptors: another cross-tolerance study. Behav Brain Res 1992, 47(2):143-149.
• [49]Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC, Hao JX, Terenius L: Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain 1991, 47(3):295-298.
• [50]Wang Y, Zhang Y, Wang W, Cao Y, Han JS: Effects of synchronous or asynchronous electroacupuncture stimulation with low versus high frequency on spinal opioid release and tail flick nociception. Exp Neurol 2005, 192(1):156-162.
• [51]Zadina JE, Hackler L, Ge LJ, Kastin AJ: A potent and selective endogenous agonist for the mu-opiate receptor. Nature 1997, 386(6624):499-502.
• [52]Chen XH, Han JS: All three types of opioid receptors in the spinal cord are important for 2/15 Hz electroacupuncture analgesia. Eur J Pharmacol 1992, 211(2):203-210.
• [53]Bartsch T, Levy MJ, Knight YE, Goadsby PJ: Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain 2004, 109(3):367-378.
• [54]Watanabe S, Kuwaki T, Yanagisawa M, Fukuda Y, Shimoyama M: Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport 2005, 16(1):5-8.
• [55]Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F, Ito S, Hayashi Y, Sasano H, Mouri T: Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides 2000, 21(4):565-570.
• [56]Abramova TV, Novikova NS, Perekrest SV, Rogers VJ, Korneva EA: Responses of hypothalamic orexin-containing neurons to cyclophosphamide, EHF-irradiation of the skin, and their combination in rats. Pathophysiology 2007, 14(2):79-85.